# Specification Quality Checklist: Automatic Model-Specific Safety Training

**Purpose**: Validate specification completeness and quality before proceeding to planning
**Created**: 2026-10-21
**Feature**: [spec.md](../spec.md)

## Content Quality

- [x] CHK001 No implementation details prescribe a language, framework, database, API, or code structure.
- [x] CHK002 The specification focuses on research-user outcomes and the need for model-specific correctness estimation.
- [x] CHK003 User scenarios and terms are understandable to research stakeholders; technical terms are defined by their established feature contracts.
- [x] CHK004 All mandatory sections are completed: user scenarios, edge cases, functional requirements, key entities, success criteria, and assumptions.

## Requirement Completeness

- [x] CHK005 No unresolved `[NEEDS CLARIFICATION]` markers remain; the five research decisions A–E have been clarified and approved.
- [x] CHK006 Requirements specify exact inputs, scope identity, behavior, forbidden data, and expected outcomes in testable terms.
- [x] CHK007 Success criteria define observable synthetic verification outcomes and measurable zero-leakage/compatibility checks without inventing universal model-performance thresholds.
- [x] CHK008 Success criteria avoid implementation-specific performance claims and clinical effectiveness claims.
- [x] CHK009 Each user story has independent test guidance and acceptance scenarios.
- [x] CHK010 Edge cases cover source mismatch, small/imbalanced data, missing evidence, grouping, incompatibility, and protected partition boundaries.
- [x] CHK011 Included and excluded scope is explicitly bounded, including the handoff to later calibration and policy work.
- [x] CHK012 Dependencies and assumptions identify Features 001–004 and the versioned research protocol as authoritative.

## Feature Readiness

- [x] CHK013 Every functional requirement maps to one or more acceptance scenarios or success criteria through explicit source, scope, leakage, artifact, and failure behavior.
- [x] CHK014 User scenarios cover eligibility, automatic training/selection, multi-label/multi-model isolation, and reproducible artifact review.
- [x] CHK015 Success criteria cover all stated feature outcomes, including trusted admission, patient grouping, privacy, reproducibility, and regression compatibility.
- [x] CHK016 The specification avoids prescribing unapproved estimator algorithms, architecture, imputation, metrics, minima, or partition choices.
- [x] CHK017 Correctness targets remain supervised targets only; protected evaluation data and existing Feature 001–004 contracts are explicitly protected.

## Open Research Decisions

- [x] CHK018 Decision A is resolved: the training-prevalence baseline and fixed L2 logistic candidate, scikit-learn dependency, Brier-first selection, secondary metrics, tie rule, and single-class limitation are recorded in the specification.
- [x] CHK019 Decision B is resolved: training, eligibility, candidate comparison, and artifacts are independent for each exact `(model_id, model_version, label_id)` scope.
- [x] CHK020 Decision C is resolved: the protocol-approved finite feature schema, seven distinct states, non-predictive metadata, and training-only preprocessing rules are recorded.
- [x] CHK021 Decision D is resolved: Feature 003 train fits and validation selects once; calibration and protected final-test remain unavailable, with no added CV or seed search.
- [x] CHK022 Decision E is resolved: artifacts are immutable, exact-scope, uncalibrated and non-deployable, and validation is marked spent for selection.

## Notes

- Checklist items are marked complete for specification quality, not implementation completion or scientific/clinical validation.
- The separate proposal referenced in the request was not present in the repository; the user-provided Feature 005 description is the proposal of record.
- Decisions A–E are approved and integrated. Technical planning and task generation are complete. Cross-artifact analysis identified targeted documentation corrections; implementation and empirical/scientific validation have not begun.
